Interview with Dr. Thomas Costa of Coventya

ndetails

In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.

Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.

Listen to the podcast:

You can subscribe to the podcast on your favourite podcast platform:

Spotify

Apple Podcasts

alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.

Related Insights

Mastering the new science of engineered management decision processes
28 Oct, 2024 By Humatica

Mastering the new science of engineered management decision processes

Despite huge efforts to improve operational processes over the past 20 years, critically important management processes are left up to the discretion of each manager…

Read more arrowicon
Thriving in the Storm: How Agile Organizations Outperform in Uncertain Markets
18 Sep, 2024 By Humatica

Thriving in the Storm: How Agile Organizations Outperform in Uncertain Markets

The global economy in 2024 resembles a rollercoaster more than ever before. Geopolitical tensions, technological disruptions, and shifting consumer behaviours have created a perfect storm…

Read more arrowicon
Decoding Organization and Leadership: Why the Founder vs Manager debate misses the point
10 Sep, 2024 By Humatica

Decoding Organization and Leadership: Why the Founder vs Manager debate misses the point

In the bustling world of Silicon Valley and beyond, a new paradigm is stirring up debate: “Founder Mode” vs “Manager Mode”. Paul Graham, co-founder of…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.